Lilly's Bydureon falls short of competitor in study










And the Eli Lilly FIPNET pipeline of innovation continues to amaze shareholders and strike fear in the hearts of competitors.

http://www.ibj.com/lillys-bydureon-falls-short-of-competitor-in-study/PARAMS/article/25656

P.S. Keep up the good work JL. Only a few million more and your net worth will break half a billion. You're a giant among insects.

Fear not, as our innovative pipeline runs deep and there will be no mass layoffs at Lilly. You have my word on it.

Honest John
 





Write your reply...